Literature DB >> 11559670

Nitric oxide: an emerging role in cardioprotection?

R D Rakhit1, M S Marber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11559670      PMCID： PMC1729943          DOI： 10.1136/heart.86.4.368

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  48 in total

1.  Activation of mitochondrial ATP-dependent potassium channels by nitric oxide.

Authors:  N Sasaki; T Sato; A Ohler; B O'Rourke; E Marbán
Journal:  Circulation       Date:  2000-02-01       Impact factor: 29.690

Review 2.  The cell biology of acute myocardial ischemia.

Authors:  R B Jennings; K A Reimer
Journal:  Annu Rev Med       Date:  1991       Impact factor: 13.739

Review 3.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

4.  Levels of nitric oxide in the heart after experimental myocardial ischemia.

Authors:  S Lecour; V Maupoil; M Zeller; A Laubriet; T Briot; L Rochette
Journal:  J Cardiovasc Pharmacol       Date:  2001-01       Impact factor: 3.105

5.  Nitric oxide-induced cardioprotection in cultured rat ventricular myocytes.

Authors:  R D Rakhit; R J Edwards; J W Mockridge; A R Baydoun; A W Wyatt; G E Mann; M S Marber
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-04       Impact factor: 4.733

6.  Adenosine preconditioning reduces both pre and postischemic arrhythmias in human myocardium.

Authors:  B J Pomerantz; K Joo; B D Shames; J C Cleveland; A Banerjee; A H Harken
Journal:  J Surg Res       Date:  2000-05-15       Impact factor: 2.192

Review 7.  Diastolic heart failure.

Authors:  L Mandinov; F R Eberli; C Seiler; O M Hess
Journal:  Cardiovasc Res       Date:  2000-03       Impact factor: 10.787

8.  Mitochondria as targets for nitric oxide-induced protection during simulated ischemia and reoxygenation in isolated neonatal cardiomyocytes.

Authors:  R D Rakhit; M H Mojet; M S Marber; M R Duchen
Journal:  Circulation       Date:  2001-05-29       Impact factor: 29.690

9.  Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion.

Authors:  G Johnson; P S Tsao; A M Lefer
Journal:  Crit Care Med       Date:  1991-02       Impact factor: 7.598

Review 10.  Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials.

Authors:  S Yusuf; R Collins; S MacMahon; R Peto
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321
View more
  20 in total

1.  Transforming growth factor-beta(1) expression in dilated cardiomyopathy.

Authors:  J E Sanderson; K B Lai; I O Shum; S Wei; L T Chow
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

2.  Idiopathic dilated cardiomyopathy: lack of association with haemochromatosis gene in the CARDIGENE study.

Authors:  G Hetet; B Grandchamp; C Bouchier; V Nicaud; L Tiret; G Roizès; M Desnos; K Schwartz; R Dorent; M Komajda
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

3.  Contrast enhanced magnetic resonance angiography and pulmonary venous anomalies.

Authors:  F Godart; S Willoteaux; C Rey; B Cocheteux; C Francart; J P Beregi
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

4.  Effects of cardiac resynchronisation on maximal and submaximal exercise performance in advanced heart failure patients with conduction abnormality.

Authors:  D Birnie; L P Soucie; S Smith; A S Tang
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

5.  Reciprocal increase of circulating interleukin-10 and interleukin-6 in patients with acute myocardial infarction.

Authors:  N Kotajima; T Kimura; T Kanda; A Kuwabara; Y Fukumura; M Murakami; I Kobayashi
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

6.  Percutaneous aortic valve replacement: will we get there?

Authors:  Y Boudjemline; P Bonhoeffer
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

7.  Tetrahydrobiopterin attenuates cholesterol induced coronary hyperreactivity to endothelin.

Authors:  S Verma; A S Dumont; A Maitland
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

8.  Oxygen cycling in conjunction with stem cell transplantation induces NOS3 expression leading to attenuation of fibrosis and improved cardiac function.

Authors:  Mahmood Khan; Sarath Meduru; Rajan Gogna; Esha Madan; Lucas Citro; Muthulakshmi L Kuppusamy; Muzzammil Sayyid; Mahmoud Mostafa; Robert L Hamlin; Periannan Kuppusamy
Journal:  Cardiovasc Res       Date:  2011-10-19       Impact factor: 10.787

9.  Plasma nitric oxide metabolite levels increase during successive exercise stress testing - A link to delayed ischemic preconditioning?

Authors:  Dumitru Zdrenghea; György Bódizs; Mihai Claudiu Ober; Maria Ilea
Journal:  Exp Clin Cardiol       Date:  2003

10.  Phospholemman Ser69 phosphorylation contributes to sildenafil-induced cardioprotection against reperfusion injury.

Authors:  Melanie Madhani; Andrew R Hall; Friederike Cuello; Rebecca L Charles; Joseph R Burgoyne; William Fuller; Adrian J Hobbs; Michael J Shattock; Philip Eaton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-11       Impact factor: 4.733
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.